AbbVie
ABBV
#33
Rank
$256.14 B
Marketcap
$144.84
Share price
-1.20%
Change (1 day)
4.49%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Operating Margin for AbbVie (ABBV)

Operating Margin as of February 2023 (TTM): 25.56%

According to AbbVie's latest financial reports and stock price the company's current Operating Margin is 25.56%. At the end of 2021 the company had an Operating Margin of 23.11%.

Operating Margin history for AbbVie from 2011 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202123.11%211.56%
20207.42%-70.71%
201925.33%59.63%
201815.87%-42.06%
201727.39%-10.95%
201630.75%5.79%
201529.07%144.93%
201411.87%-58.17%
201328.38%-8.9%
201231.15%48.11%
201121.03%-31.99%
201030.92%-26.13%
200941.86%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
29.90%-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
22.40%-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
29.35%-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
32.74%-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
16.73%-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
16.50%-99.87%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.70%-99.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
15.36%-99.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
8.94%-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.